INNOVIVA, INC. purchased 192.7% of their position (19.27M shares) of ENTASIS THERAPEUTICS HOLDINGS INC. on the open market
Open‑market purchase worth $42.40M — a major conviction buy. The strongest form of insider conviction signal.
Common Stock
Shares
+11.67M
Price / share
$2.20
Trade value
$25.68M
% of position
Common Stock
Shares
+7.60M
Price / share
$2.20
Trade value
$16.72M
% of position
Net shares
+19.27M
Net value
$42.40M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 7/8/2022 | P · Purchase | +11.67M | $2.20 | $25.68M | 116.7% | 10M | 21.67M |
| Common Stock Indirect | 7/11/2022 | P · Purchase | +7.60M | $2.20 | $16.72M | 35.1% | 21.67M | 29.27M |
| Total | +19.27M | $42.40M | ||||||
Common Stock
Direct| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 18.67M | Direct |
| Total | 18.67M | 18.67M direct |
Warrants to Purchase Common Stock
IndirectUnderlying shares
N/A
Shares owned
10M
Exercise price
Expiration
—
Exercise window
—
Warrants to Purchase Common Stock
DirectUnderlying shares
N/A
Shares owned
18.67M
Exercise price
Expiration
—
Exercise window
—
Convertible Promissory Note
IndirectUnderlying shares
N/A
Shares owned
0.00
Exercise price
Expiration
—
Exercise window
—
Underlying
0.00
Owned
28.67M
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Warrants to Purchase Common Stock Indirect | Common Stock | — | — | N/A | 10M | |
| Warrants to Purchase Common Stock Direct | Common Stock | — | — | N/A | 18.67M | |
| Convertible Promissory Note Indirect | Common Stock | — | — | N/A | 0.00 | |
| Total | 0.00 | 28.67M | ||||